Correlation Between OBI Pharma and China Glaze
Can any of the company-specific risk be diversified away by investing in both OBI Pharma and China Glaze at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OBI Pharma and China Glaze into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OBI Pharma and China Glaze Co, you can compare the effects of market volatilities on OBI Pharma and China Glaze and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OBI Pharma with a short position of China Glaze. Check out your portfolio center. Please also check ongoing floating volatility patterns of OBI Pharma and China Glaze.
Diversification Opportunities for OBI Pharma and China Glaze
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between OBI and China is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding OBI Pharma and China Glaze Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Glaze and OBI Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OBI Pharma are associated (or correlated) with China Glaze. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Glaze has no effect on the direction of OBI Pharma i.e., OBI Pharma and China Glaze go up and down completely randomly.
Pair Corralation between OBI Pharma and China Glaze
Assuming the 90 days trading horizon OBI Pharma is expected to generate 0.93 times more return on investment than China Glaze. However, OBI Pharma is 1.08 times less risky than China Glaze. It trades about -0.01 of its potential returns per unit of risk. China Glaze Co is currently generating about -0.05 per unit of risk. If you would invest 6,030 in OBI Pharma on October 25, 2024 and sell it today you would lose (310.00) from holding OBI Pharma or give up 5.14% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
OBI Pharma vs. China Glaze Co
Performance |
Timeline |
OBI Pharma |
China Glaze |
OBI Pharma and China Glaze Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with OBI Pharma and China Glaze
The main advantage of trading using opposite OBI Pharma and China Glaze positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OBI Pharma position performs unexpectedly, China Glaze can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Glaze will offset losses from the drop in China Glaze's long position.OBI Pharma vs. TaiMed Biologics | OBI Pharma vs. PharmaEngine | OBI Pharma vs. Medigen Biotechnology | OBI Pharma vs. TTY Biopharm Co |
China Glaze vs. Nan Ya Plastics | China Glaze vs. Formosa Chemicals Fibre | China Glaze vs. China Steel Corp | China Glaze vs. Formosa Petrochemical Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |